Stoke Therapeutics, Inc. (NASDAQ:STOK)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Loses money on what it sells.
- Revenue
- $27.6M
- Net income
- -$207.9M
- Net margin
- -753.6%
Little or no net debt.
- Total debt
- $2.7M
- Cash
- $110.0M
- Debt / equity
- 0.01
Comfortably covers what is due within a year.
- Current assets
- $322.5M
- Current liabilities
- $41.9M
- Current ratio
- 7.69
Consumes cash and must keep raising it.
- Operating cash flow
- -$178.0M
- Free cash flow
- -$180.7M
- FCF margin
- -654.9%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 66.0M
- Share growth (1y)
- 13.1%
- Cash runway
- 7 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
STOK Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 9.32 M | 6.23 M | 1.40 M | 10.63 M | 13.82 M | 158.57 M |
| Revenue Growth (YoY) | -32.51 % | -96.07 % | -93.80 % | 117.25 % | 186.01 % | 3661.12 % |
| Cost of Revenue | 1.14 M | 1.05 M | 1.05 M | 989.00 K | 0.00 | 0.00 |
| Gross Profit | 8.19 M | 5.18 M | 347.00 K | 9.64 M | 13.82 M | 158.57 M |
| SG&A Expense | 24.57 M | 19.97 M | 20.50 M | 15.48 M | 15.26 M | 14.65 M |
| R&D Expense | 49.04 M | 39.67 M | 41.29 M | 37.25 M | 25.86 M | 32.68 M |
| Operating Expenses | 73.62 M | 58.60 M | 61.79 M | 52.73 M | 41.12 M | 47.33 M |
| Operating Income | -65.43 M | -53.42 M | -61.44 M | -43.09 M | -27.30 M | 111.24 M |
| Pretax Income | -61.62 M | -50.00 M | -57.93 M | -39.63 M | -23.48 M | 114.16 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | -1.28 M | 0.00 | 1.28 M |
| Net Income | -61.62 M | -50.00 M | -57.93 M | -38.35 M | -23.48 M | 112.88 M |
| EPS (Basic) | -0.93 | -0.79 | -0.99 | -0.65 | -0.40 | 1.95 |
| EPS (Diluted) | -0.93 | -0.79 | -0.99 | -0.65 | -0.40 | 1.90 |
| Shares Outstanding | 66.02 M | 63.06 M | 58.39 M | 58.61 M | 58.35 M | 57.86 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.